Literature DB >> 26356041

Diurnal salivary cortisol, glycemia and insulin resistance: The multi-ethnic study of atherosclerosis.

Joshua J Joseph1, Xu Wang2, Elias Spanakis3, Teresa Seeman4, Gary Wand1, Belinda Needham5, Sherita Hill Golden6.   

Abstract

Hypercortisolism is associated with insulin resistance (IR) and diabetes mellitus (DM); however, to our knowledge prior studies have not examined the association of diurnal cortisol curve features with measures of glycemia or IR in a population-based setting. Using log-transformed salivary cortisol data on 850 ethnically diverse men and women from the Multi-Ethnic Study of Atherosclerosis, we investigated the cross-sectional association of cortisol curve features with (1) glycemia in those with and without DM and (2) IR, in non-diabetic subjects. The log-transformed salivary cortisol curve features included wake-up cortisol, cortisol awakening response (CAR), early decline slope (30min to 2h post-awakening), late decline slope (2h post-awakening to bedtime), overall decline slope (0min to bedtime, excluding 30min cortisol), bedtime cortisol and total area under the curve (AUC). Overall, following multivariable adjustment, among those with diabetes mellitus (DM), early decline slope, overall decline slope, bedtime cortisol, and AUC were significantly and positively associated with a 5.4% (95% CI: 1.3, 9.7), 54.7% (95% CI: 12.4, 112.9), 4.0% (95% CI: 1.6,6.4), and 6.8% (95% CI: 3.3,10.4) higher HbA1c per 1 unit increase in log cortisol feature, respectively. Cortisol curve features were not associated with HbA1c among non-diabetic participants; however, wake-up cortisol and AUC were associated with a 8.2% lower (95% CI: -13.3,-2.7) and 7.9% lower (95% CI: -14.6, -0.6) log HOMA-IR, respectively. This was attenuated by adjustment for waist circumference. Among participants with DM, cortisol curve parameters suggestive of higher hypothalamic-pituitary-adrenal (HPA) axis activity and dysfunction were associated with higher HbA1c. In non-diabetic participants, greater HPA activity was paradoxically associated with lower insulin resistance.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cortisol; Glycemia; Hypothalamic-pituitary-adrenal axis; Insulin resistance; Type 2 Diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 26356041      PMCID: PMC4637243          DOI: 10.1016/j.psyneuen.2015.08.021

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  46 in total

Review 1.  The awakening cortisol response: methodological issues and significance.

Authors:  A Clow; L Thorn; P Evans; F Hucklebridge
Journal:  Stress       Date:  2004-03       Impact factor: 3.493

2.  Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

Authors:  F Delaunay; A Khan; A Cintra; B Davani; Z C Ling; A Andersson; C G Ostenson; J Gustafsson; S Efendic; S Okret
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Associations between self-reported discrimination and diurnal cortisol rhythms among young adults: The moderating role of racial-ethnic minority status.

Authors:  Katharine H Zeiders; Lindsay T Hoyt; Emma K Adam
Journal:  Psychoneuroendocrinology       Date:  2014-09-16       Impact factor: 4.905

4.  A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.

Authors:  K C Yeh; K C Kwan
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

5.  Stability and predictors of change in salivary cortisol measures over six years: MESA.

Authors:  Xu Wang; Brisa N Sánchez; Sherita Hill Golden; Sandi Shrager; Clemens Kirschbaum; Arun S Karlamangla; Teresa E Seeman; Ana V Diez Roux
Journal:  Psychoneuroendocrinology       Date:  2014-08-04       Impact factor: 4.905

Review 6.  Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes?

Authors:  Roland Rosmond
Journal:  Med Sci Monit       Date:  2003-02

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

8.  Insulin and cortisol promote leptin production in cultured human fat cells.

Authors:  M Wabitsch; P B Jensen; W F Blum; C T Christoffersen; P Englaro; E Heinze; W Rascher; W Teller; H Tornqvist; H Hauner
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

9.  Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans.

Authors:  J W Newcomer; G Selke; A K Melson; J Gross; G P Vogler; S Dagogo-Jack
Journal:  Arch Gen Psychiatry       Date:  1998-11

10.  Increased glucocorticoid sensitivity in islet beta-cells: effects on glucose 6-phosphatase, glucose cycling and insulin release.

Authors:  Z C Ling; A Khan; F Delauny; B Davani; C G Ostenson; J A Gustafsson; S Okret; B R Landau; S Efendic
Journal:  Diabetologia       Date:  1998-06       Impact factor: 10.122

View more
  20 in total

1.  The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.

Authors:  Robin Ortiz; Bjoern Kluwe; James B Odei; Justin B Echouffo Tcheugui; Mario Sims; Rita R Kalyani; Alain G Bertoni; Sherita H Golden; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2018-12-27       Impact factor: 4.905

2.  Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus?

Authors:  Hershel Raff; Steven B Magill
Journal:  Endocrine       Date:  2016-09-30       Impact factor: 3.633

3.  IN MY OWN WORDS: THE VALUE OF STORYTELLING TO SHAPE THE ACADEMIC MEDICINE JOURNEY.

Authors:  Sherita Hill Golden
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

4.  Antecedent longitudinal changes in body mass index are associated with diurnal cortisol curve features: The multi-ethnic study of atherosclerosis.

Authors:  Joshua J Joseph; Xu Wang; Ana V Diez Roux; Brisa N Sanchez; Teresa E Seeman; Belinda L Needham; Sherita Hill Golden
Journal:  Metabolism       Date:  2016-12-08       Impact factor: 8.694

5.  Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis.

Authors:  Elias K Spanakis; Xu Wang; Brisa N Sánchez; Ana V Diez Roux; Belinda L Needham; Gary S Wand; Teresa Seeman; Sherita Hill Golden
Journal:  Endocrine       Date:  2016-02-19       Impact factor: 3.633

6.  Inflammation and Stress Biomarkers Mediate the Association between Household Food Insecurity and Insulin Resistance among Latinos with Type 2 Diabetes.

Authors:  Angela Bermúdez-Millán; Julie A Wagner; Richard S Feinn; Sofia Segura-Pérez; Grace Damio; Jyoti Chhabra; Rafael Pérez-Escamilla
Journal:  J Nutr       Date:  2019-06-01       Impact factor: 4.798

7.  Does sleep duration, napping, and social jetlag predict hemoglobin A1c among college students with type 1 diabetes mellitus?

Authors:  Jennifer Saylor; Xiaopeng Ji; Christina J Calamaro; Adam Davey
Journal:  Diabetes Res Clin Pract       Date:  2019-01-11       Impact factor: 5.602

Review 8.  Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.

Authors:  Joshua J Joseph; Sherita H Golden
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

9.  The longitudinal association of changes in diurnal cortisol features with fasting glucose: MESA.

Authors:  Jenny Pena Dias; Joshua J Joseph; Bjorn Kluwe; Songzhu Zhao; Michelle Shardell; Teresa Seeman; Belinda L Needham; Gary S Wand; David Kline; Guy Brock; Cecilia Castro-Diehl; Sherita Hill Golden
Journal:  Psychoneuroendocrinology       Date:  2020-07-13       Impact factor: 4.905

10.  Insufficient glucocorticoid receptor signaling and flattened salivary cortisol profile are associated with metabolic and inflammatory indices in type 2 diabetes.

Authors:  C Panagiotou; V Lambadiari; E Maratou; C Geromeriati; A Artemiadis; G Dimitriadis; P Moutsatsou
Journal:  J Endocrinol Invest       Date:  2020-05-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.